Ipso Ventures Share Discussion Threads

[electrick] 20/10/2011 16:31

gone very quiet on this board...... everyone got me on filter?? i guess so!!

is there ANY rational why purchasing this would be a profitable inverstment over a 6 month period? what tech or events will likely effect the SP?

Come on I promise not to simply slam... I will look to rationale discussion :o)

[tomboyb] 19/10/2011 15:03

There has been selling pressure here - looking at those trades close apart as have been others - it could be stop losses being triggered by MMs - I could be wrong but MMs offering still 100k MAX online -

[tomboyb] 19/10/2011 14:27

Market cap Now 1.2mill

Take away Ipsol Energy at £467k - it values all other investments including Therakind at 750k!

[electrick] 18/10/2011 00:38

no one think i just may be right??

[tomboyb] 17/10/2011 15:58

MMs have taken a lot of stock on their books - just waiting ------

[electrick] 15/10/2011 09:21

lol... yep maybe he is so angry he is happy to get rid of all his potential millions!!! I love the optimism on here!!!

[electrick] 14/10/2011 18:58

Hmmmn why wouldnt he want to holdem?? cuh - probably because he knows they wont be worth anything soon
have a good weekend

[nidgeyr] 14/10/2011 17:40

Simon Hunt what a £$%t

[tomboyb] 14/10/2011 11:35

Wait for the sellers to go before buying - capped now at 1.4mill -

[electrick] 14/10/2011 10:56

hmmmn continous slide... perhaps today is the day for 3p

[tomboyb] 12/10/2011 15:41

Prof. Dermot Kelleher, Vice-Provost for Medical Affairs, Trinity College Dublin (TCD) said: "We are encouraged by Kernel Capital's investment in Biocroí which provides vital resources to move this TCD innovation along the development roadway toward a most valuable product for new medicine development globally."

BioCroi Ltd dos look v interesting -

[tomboyb] 12/10/2011 14:29

Most of IPSO's investment is on healthcare so to see IPSOL nergy go up in value is not a bad sigh -

On a smaller Note:



Kernel Capital leads €800K investment in Trinity College spin-out BioCroi Ltd

Kernel Capital through the Bank of Ireland MedTech Accelerator Fund has led an €800k investment in Trinity College spin-out Biocroí Ltd, a medical technology company. The syndicated investment comprises of a €500k investment by the Bank of Ireland MedTech Accelerator Fund, with the remainder of the funds provided by Enterprise Ireland and private investors.

[electrick] 12/10/2011 09:10

they have some more cash now... just a bit less of the company...

s
l
i
d
e

[tomboyb] 12/10/2011 08:56

Oh dear - wind-up merchant - They have cash till ast least quarter 3 2012 -

Your revenue does not consider investment value - IPO it's big brother has a market cap of 225mill but revenue of £1.1mill - why? cash and investments -

This is a tech investing company - same as IPO and imperial innovations -

Oh dear!

[electrick] 12/10/2011 08:51

TUT... delusional ... dilution to ensure cash to continue... why??? cash burn is too quick... not going well is it... IPSol may yet be accredited... just not going well... perhaps it will get sub 4p today... before that gentle slide back to 3p....

[electrick] 12/10/2011 08:34

Yep... I am sure you ae delighted that they have burnt the last lot of cash and need more ??? why?? BECAUSE THERE IS NO REVENUE ......

[tomboyb] 12/10/2011 08:08

Theyn held 30-odd % before so its a buisness increasing in value for IPS -

[electrick] 12/10/2011 08:01

Gosh... that's a surprise :o)

[tomboyb] 12/10/2011 07:56

TIDMIPS

RNS Number : 0024Q

Ipso Ventures PLC

12 October 2011

12 October 2011

IPSO Ventures plc

IPSol Energy successful fund raising

IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, is delighted to announce that its portfolio company, IPSol Energy Limited ("IPSol Energy") has raised a further GBP265,000 to fund the expansion of its business.

IPSol Energy provides business and technical solutions to the Solar Photovoltaic ("PV") market with an initial focus on testing services. It has established the UK's first accredited commercial PV module testing facility in Nottingham, providing manufacturers and installers of solar PV modules with third party accreditation and validation of their products.

Following this fund raising IPSO has a 27.3% shareholding in IPSol Energy which is now valued by IPSO's management at GBP459,000, based on the price at which the new shares have been allotted, an increase of GBP111,000 compared with the value as at 30(th) April 2011.

Craig Rochford, Chairman of IPSO said: "We are very pleased that IPSol Energy has been successful in securing additional financial support to expand its business."

Peter Khoury, Chief Executive of IPSol Energy said: "Our success with this fund raising is testament to the fact that the IPSol team have exceeded the original expectations for the business."

For further information, please contact:


IPSO Ventures plc Tel: [phone]
Craig Rochford, Chairman [e-mail]
Nick Rodgers, Chief Executive Officer [e-mail]
www.ipsoventures.com
Allenby Capital Limited Tel: [phone]
(nominated adviser and broker)
Nick Naylor
Nick Athanas

Notes to editors

Company description

IPSO Ventures plc is a business creator and active investor in new technologies, principally in the renewable energy and healthcare sector. Its experienced management team focuses on adding commercial value to enable young companies to move forward rapidly.

This information is provided by RNS

The company news service from the London Stock Exchange

END